Pitch Perfect – Driving Innovation in Dementia with Alzheimer’s Society

Presenters confirmed:

• Kneu Health – a pioneering continuous intelligence for neurological care, using smartphone-based monitoring to support earlier detection and personalised care in dementia and Parkinson’s. ​Built on Oxford University research and FDA-cleared, the Kneu platform is operational across leading health systems and NHS trusts. Kneu Health was on our Alzheimer’s Society Accelerator in 2025/2026.

• Punto Health – Punto Health is an AI-powered digital platform for dementia management. It acts as a post-diagnosis coordination platform, focusing on personalised treatment and support, and improved coordination and monitoring. Its three modules, PuntoCare, PuntoTest, and PuntoClinic, provide continuous support for patients and carers, scalable cognitive assessment, and clinical insights for professionals. Punto Care is the element we are supporting on our Accelerator Programme.
• 6D Dementia (Frances Duffy was previously on CEP and now on our Accelerator Programme!) – 6D Dementia equips staff across health and social care and families with practical micro-skills and a shared framework to respond with empathy and consistency so that everyday interactions become therapeutic, reducing crises, admissions, and antipsychotic use, while supporting stable living arrangements, promoting independence, and strengthening the workforce and family network.
• Jelly Drops – Jelly Drops are sugar-free (and vegan) sweets which are 95% water with added electrolytes and vitamins. Lewis was inspired to create water sweets after his grandma Pat, who had dementia, was struggling to hydrate. Testing Jelly Drops in a hospital setting is something the team are already exploring and would find it really valuable to have other opportunities like this, particularly in looking at the links between hospital admissions and hydration.

About the Session & the Alzheimer’s Society:

• Pitch Perfect is a virtual showcase series hosted by the NHS InSites Hub team, designed to highlight innovative healthcare solutions from across the NHS and nationally supported programmes. Each session features rapid-fire 3-minute pitches from NHS staff, clinical entrepreneurs, and startup founders, followed by live Q&A and open discussion. The sessions foster cross-site collaboration, peer learning, and visibility for early-stage innovations, helping accelerate the adoption of impactful ideas that address real-world challenges in care delivery.

• Alzheimer’s Society is the UK’s leading dementia charity. We give vital support to those who need it, fund groundbreaking research and innovation, and campaign to improve experiences. We’re here to ensure that the impact we make is felt in the day-to-day lives of people and families now and in the future. We’re leading the way to create a future where dementia no longer devastates lives, bringing together people from all the spheres of life dementia touches

• Dementia is the greatest health and social care challenge of our time. Almost one million people are living with dementia right now in the UK. By 2040, that figure is expected to rise to 1.4m. It will take a society to beat dementia. ​Alzheimer’s Society has set an ambitious goal of stopping dementia from devastating lives by 2050. This cannot be achieved without innovation, transforming the lives of people affected by dementia and the systems that support them.

• At Alzheimer’s Society, we identify, support and invest in innovations and bring the best innovators and entrepreneurs into dementia. Our Innovation Programme and strategic partnerships support individuals and businesses throughout their innovation journey – from the earliest stage dementia product ideas through to market and implementation. ​To date, we have supported over 80 products and innovations through our Innovation Programme, which are providing help right now and hope for the future. These have reached more than 1.5 million people and have enabled our Innovation partners to generate more than £13.5million in follow-on funding. ​Through harnessing ground-breaking new technology and tackling the big underlying system challenges of diagnosis and access to treatments, we can change the future for people affected by dementia. Find out more about dementia innovation at Alzheimer’s Society.

Register